Sustained Viral Suppression in HIV-Infected Patients Receiving Antiretroviral Therapy

被引:74
|
作者
Yehia, Baligh R. [1 ]
Fleishman, John A. [2 ]
Metlay, Joshua P. [1 ]
Moore, Richard D. [3 ]
Gebo, Kelly A. [3 ]
机构
[1] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Agcy Healthcare Res & Qual, Ctr Financing Access & Cost Trends, Rockville, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
来源
关键词
D O I
10.1001/jama.2012.5927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:339 / 342
页数:4
相关论文
共 50 条
  • [1] Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy
    Glass, Tracy R.
    Rotger, Margalida
    Telenti, Amalio
    Decosterd, Laurent
    Csajka, Chantal
    Bucher, Heiner C.
    Guenthard, Huldrych F.
    Rickenbach, Martin
    Nicca, Dunja
    Hirschel, Bernard
    Bernasconi, Enos
    Wandeler, Gilles
    Battegay, Manuel
    Marzolini, Catia
    PLOS ONE, 2012, 7 (01):
  • [2] Gynecomastia in HIV-infected patients receiving antiretroviral therapy
    García-Benayas, T
    Blanco, F
    Martín-Carbonero, L
    Valencia, E
    Barrios, A
    González-Lahoz, J
    Soriano, V
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (09) : 739 - 741
  • [3] Dolutegravir monotherapy in HIV-infected patients with sustained viral suppression
    Rojas, Jhon
    Blanco, Jose L.
    Marcos, Maria A.
    Lonca, Montserrat
    Tricas, Amparo
    Moreno, Laura
    Gonzalez-Cordon, Ana
    Torres, Berta
    Mallolas, Josep
    Garcia, Federico
    Gatell, Jose M.
    Martinez, Esteban
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (07) : 1975 - 1981
  • [4] Durable viral suppression in an HIV-infected patient in the absence of antiretroviral therapy
    Bon, Isabella
    Musumeci, Giuseppina
    Pavoni, Michele
    Miserocchi, Anna
    Lo Presti, Alessandra
    Morini, Silvia
    Caio, Giacomo
    Della Vittoria, Agnese
    Gibellini, Davide
    Re, Maria Carla
    NEW MICROBIOLOGICA, 2015, 38 (02): : 289 - 292
  • [5] Metabolic disorders in HIV-infected patients receiving antiretroviral therapy
    Kanestri, V.
    Kravchenko, A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [6] Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy
    Martínez, E
    Tuset, M
    Milinkovic, A
    Miró, JM
    Gatell, JM
    ANTIVIRAL THERAPY, 2004, 9 (05) : 649 - 663
  • [7] Diabetes mellitus in HIV-infected patients receiving antiretroviral therapy
    Moyo, D.
    Tanthuma, G.
    Mushisha, O.
    Kwadiba, G.
    Chikuse, F.
    Cary, M. S.
    Steenhoff, A. P.
    Reid, M. J. A.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2014, 104 (01): : 37 - 39
  • [8] Nitric oxide levels in HIV-infected, untreated patients and HIV-infected patients receiving antiretroviral therapy
    Soccal, Renata Mezomo
    Mainardi de Carvalho, Jose Antonio
    Bochi, Guilherme Vargas
    Moresco, Rafael Noal
    Paz da Silva, Jose Edson
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 302 - 307
  • [9] Viral Suppression in a Nationwide Sample of HIV-Infected Children on Antiretroviral Therapy in Rwanda
    Nsanzimana, Sabin
    McArdle, Flannery
    Remera, Eric
    Mulindabigwi, Augustin
    Ribakare, Muhayimpundu
    Ndimubanzi, Patrick
    Kayirangwa, Eugenie
    Baribwira, Cyprien
    Riedel, David J.
    Ntaganira, Joseph
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (02) : 149 - 151
  • [10] QT Dispersion in HIV-Infected Patients Receiving Combined Antiretroviral Therapy
    Wongcharoen, Wanwarang
    Suaklin, Somkhuan
    Tantisirivit, Nualnit
    Phrommintikul, Arintaya
    Chattipakorn, Nipon
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2014, 19 (06) : 561 - 566